98 related articles for article (PubMed ID: 8605019)
1. Regulation of fatty acid synthase expression by cholesterol in human cultured cells.
Kawabe Y; Sato R; Matsumoto A; Honda M; Wada Y; Yazaki Y; Endo A; Takano T; Itakura H; Kodama T
Biochem Biophys Res Commun; 1996 Feb; 219(2):515-20. PubMed ID: 8605019
[TBL] [Abstract][Full Text] [Related]
2. Compensatory responses to inhibition of hepatic squalene synthase.
Lopez D; Chambers CM; Keller RK; Ness GC
Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
[TBL] [Abstract][Full Text] [Related]
3. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
Ness GC; Zhao Z; Keller RK
Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
[TBL] [Abstract][Full Text] [Related]
4. The molecular mechanism of the induction of the low density lipoprotein receptor by chenodeoxycholic acid in cultured human cells.
Kawabe Y; Shimokawa T; Matsumoto A; Honda M; Wada Y; Yazaki Y; Endo A; Itakura H; Kodama T
Biochem Biophys Res Commun; 1995 Mar; 208(1):405-11. PubMed ID: 7887956
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
Peffley DM; Gayen AK
Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.
Ness GC; Zhao Z; Lopez D
Arch Biochem Biophys; 1996 Jan; 325(2):242-8. PubMed ID: 8561503
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cholesterol 7 alpha-hydroxylase gene expression in Hep-G2 cells. Effect of serum, bile salts, and coordinate and noncoordinate regulation with other sterol-responsive genes.
Taniguchi T; Chen J; Cooper AD
J Biol Chem; 1994 Apr; 269(13):10071-8. PubMed ID: 8144506
[TBL] [Abstract][Full Text] [Related]
8. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by sterols and nonsterols in rat liver.
Ness GC; Eales S; Lopez D; Zhao Z
Arch Biochem Biophys; 1994 Feb; 308(2):420-5. PubMed ID: 8109970
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of squalene synthase and squalene epoxidase in tobacco cells triggers an up-regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase.
Wentzinger LF; Bach TJ; Hartmann MA
Plant Physiol; 2002 Sep; 130(1):334-46. PubMed ID: 12226513
[TBL] [Abstract][Full Text] [Related]
10. A Link between cholesterol levels and phenobarbital induction of cytochromes P450.
Ourlin JC; Handschin C; Kaufmann M; Meyer UA
Biochem Biophys Res Commun; 2002 Feb; 291(2):378-84. PubMed ID: 11846416
[TBL] [Abstract][Full Text] [Related]
11. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
Keller RK; Zhao Z; Chambers C; Ness GC
Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
[TBL] [Abstract][Full Text] [Related]
12. The physiological role of sterol regulatory element-binding protein-2 in cultured human cells.
Kawabe Y; Suzuki T; Hayashi M; Hamakubo T; Sato R; Kodama T
Biochim Biophys Acta; 1999 Jan; 1436(3):307-18. PubMed ID: 9989262
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cholesterol 7 alpha-hydroxylase expression by sterols in primary rat hepatocyte cultures.
Doerner KC; Gurley EC; Vlahcevic ZR; Hylemon PB
J Lipid Res; 1995 Jun; 36(6):1168-77. PubMed ID: 7665995
[TBL] [Abstract][Full Text] [Related]
14. Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation.
Brusselmans K; Timmermans L; Van de Sande T; Van Veldhoven PP; Guan G; Shechter I; Claessens F; Verhoeven G; Swinnen JV
J Biol Chem; 2007 Jun; 282(26):18777-85. PubMed ID: 17483544
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin modulates the heat shock response and cytotoxicity mediated by oxidized LDL in cultured human endothelial smooth muscle cells.
Pirillo A; Jacoviello C; Longoni C; Radaelli A; Catapano AL
Biochem Biophys Res Commun; 1997 Feb; 231(2):437-41. PubMed ID: 9070296
[TBL] [Abstract][Full Text] [Related]
16. Hepatic farnesyl diphosphate synthase expression is suppressed by polyunsaturated fatty acids.
Le Jossic-Corcos C; Gonthier C; Zaghini I; Logette E; Shechter I; Bournot P
Biochem J; 2005 Feb; 385(Pt 3):787-94. PubMed ID: 15473864
[TBL] [Abstract][Full Text] [Related]
17. Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase.
Bergstrom JD; Dufresne C; Bills GF; Nallin-Omstead M; Byrne K
Annu Rev Microbiol; 1995; 49():607-39. PubMed ID: 8561474
[TBL] [Abstract][Full Text] [Related]
18. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of squalene synthase upregulates PCSK9 expression in rat liver.
Bedi M; Niesen M; Lopez D
Arch Biochem Biophys; 2008 Feb; 470(2):116-9. PubMed ID: 18054775
[TBL] [Abstract][Full Text] [Related]
20. The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.
Procopiou PA; Cox B; Kirk BE; Lester MG; McCarthy AD; Sareen M; Sharratt PJ; Snowden MA; Spooner SJ; Watson NS; Widdowson J
J Med Chem; 1996 Mar; 39(7):1413-22. PubMed ID: 8691471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
